NDAORALTABLET
Approved
Nov 2020
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
Drug data last refreshed Yesterday · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SUTAB is an oral tablet formulation containing sodium sulfate, magnesium sulfate, and potassium chloride approved by the FDA in November 2020. It is indicated for bowel cleansing prior to colonoscopy or other gastrointestinal procedures. The product works as an osmotic laxative, drawing water into the intestines to promote evacuation of bowel contents. SUTAB represents a tablet-based alternative to traditional liquid bowel prep solutions, offering improved patient convenience and tolerability.
$0.0BPart D
11.2 years to LOEMechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
SUTAB employment opportunities are limited, with zero linked job openings currently identified. Roles supporting this product would typically include brand managers, gastroenterology-focused medical science liaisons (MSLs), and field representatives targeting gastroenterologists and ambulatory surgery centers. Success in this role requires expertise in gastrointestinal procedure protocols, understanding of patient compliance barriers in bowel preparation, and ability to communicate product advantages in a specialized clinical setting.
Company
Worked on SUTAB at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.